Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-18-051547)

Filing Details

Accession Number:
0001209191-18-051547
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-09-18 18:12:24
Reporting Period:
2018-09-14
Accepted Time:
2018-09-18 18:12:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1339970 Atyr Pharma Inc LIFE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1305178 Marie Jill Broadfoot 3545 John Hopkins Court, Suite 250
San Diego CA 92121		 Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-09-14 26,000 $0.73 26,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents weighted average price for the shares. The shares were purchased at price ranging from $0.729 to $0.736 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.